PIERIS PHARMACEUTICALS, INC. Uncategorized Contracts & Agreements

41 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Description of Securities
PIERIS PHARMACEUTICALS, INC.
Biotechnology
2025
Offer Letter, dated August 19, 2019, by and between Kathleen Goin and Palvella Therapeutics, Inc
PIERIS PHARMACEUTICALS, INC.
Biotechnology
2024
Offer Letter, dated July 27, 2020, by and between Jeffrey Martini and Palvella Therapeutics, Inc
PIERIS PHARMACEUTICALS, INC.
Biotechnology
2024
Offer Letter, dated August 31, 2018, by and between Kathleen A. McGowan and Palvella Therapeutics, Inc
PIERIS PHARMACEUTICALS, INC.
Biotechnology
2024
Form of Lock-Up Agreement
PIERIS PHARMACEUTICALS, INC.
Biotechnology
2024
Form of Pieris Support Agreement
PIERIS PHARMACEUTICALS, INC.
Biotechnology
DE
2024
Form of Contingent Value Rights Agreement
PIERIS PHARMACEUTICALS, INC.
Biotechnology
CO
2024
Form of Palvella Support Agreement
PIERIS PHARMACEUTICALS, INC.
Biotechnology
DE
2024
Non-Exclusive Anticalin Platform Technology License Agreement by and among the Registrant, Pieris Pharmaceuticals GmbH and Seagen, Inc., dated February 8, 2018
PIERIS PHARMACEUTICALS, INC.
Biotechnology
NY
2024
License and Collaboration Agreement by and among the Registrant, Pieris GmbH and Seagen, Inc., dated February 8, 2018
PIERIS PHARMACEUTICALS, INC.
Biotechnology
NY
2024
Retention Letter by and between Pieris GmbH and Shane Olwill, Ph.D., dated February 22, 2024
PIERIS PHARMACEUTICALS, INC.
Biotechnology
2024
Amendments to the Employment Agreement by and between Pieris GmbH and Shane Olwill, Ph.D., dated between 2012-2021
PIERIS PHARMACEUTICALS, INC.
Biotechnology
2024
Employment Agreement by and between Pieris GmbH and Shane Olwill, Ph.D. dated May 9, 2011
PIERIS PHARMACEUTICALS, INC.
Biotechnology
2024
Amendment No. 1, dated December 11, 2023, to Consulting Agreement by and between the Registrant and Ahmed Mousa
PIERIS PHARMACEUTICALS, INC.
Biotechnology
2024
Amendment No. 4 to Lease Agreement by and between Pieris GmbH and Hallbergmoos Grundvermgen GmbH, dated December 15, 2023 (English translation)
PIERIS PHARMACEUTICALS, INC.
Biotechnology
2024
Amendment No. 3 to Lease Agreement by and between Pieris GmbH and Hallbergmoos Grundvermgen GmbH, dated May 19, 2020 (English translation)
PIERIS PHARMACEUTICALS, INC.
Biotechnology
2024
Combination Study Agreement, dated March 24, 2021, by and among Pieris Pharmaceuticals, Inc. and Seagen Inc
PIERIS PHARMACEUTICALS, INC.
Biotechnology
2021
Amendment No. 1 to the February 8, 2018 Platform Agreement by and among Pieris Pharmaceuticals, Inc. and Pieris Pharmaceuticals GmbH and Seattle Genetics, Inc
PIERIS PHARMACEUTICALS, INC.
Biotechnology
2020
Letter Agreement by and between the Registrant and Louis A. Matis, M.D., dated as of January 8, 2020
PIERIS PHARMACEUTICALS, INC.
Biotechnology
2020
Description of Registered Securities
PIERIS PHARMACEUTICALS, INC.
Biotechnology
2020
Subtenant Recognition and Attornment Agreement, by and among Pieris Pharmaceuticals, Inc., 225 State Street, LLC, and Berenberg Capital Markets LLC, dated as of May 31, 2019
PIERIS PHARMACEUTICALS, INC.
Biotechnology
2019
Open Market Sale Agreement, dated as of August 9, 2019, by and between Pieris Pharmaceuticals, Inc. and Jefferies LLC
PIERIS PHARMACEUTICALS, INC.
Biotechnology
2019
CONFIDENTIAL TREATMENT REQUESTED
PIERIS PHARMACEUTICALS, INC.
Biotechnology
2017
CONFIDENTIAL TREATMENT REQUESTED
PIERIS PHARMACEUTICALS, INC.
Biotechnology
MA
2017
CONFIDENTIAL TREATMENT REQUESTED
PIERIS PHARMACEUTICALS, INC.
Biotechnology
MA
2017
CONFIDENTIAL TREATMENT REQUESTED EXCLUSIVE OPTION AGREEMENT
PIERIS PHARMACEUTICALS, INC.
Biotechnology
2017
EMPLOYMENTAGREEMENT
PIERIS PHARMACEUTICALS, INC.
Biotechnology
NV
2015
CONFIDENTIAL TREATMENT REQUESTED RESEARCH AND LICENSING AGREEMENT between
PIERIS PHARMACEUTICALS, INC.
Biotechnology
2015
CONFIDENTIAL TREATMENT REQUESTED
PIERIS PHARMACEUTICALS, INC.
Biotechnology
2015
CONFIDENTIAL TREATMENT REQUESTED
PIERIS PHARMACEUTICALS, INC.
Biotechnology
NY
2015
SPLIT-OFF AGREEMENT
PIERIS PHARMACEUTICALS, INC.
Biotechnology
NY
2014
Agreement by and between
PIERIS PHARMACEUTICALS, INC.
Biotechnology
2014
Ruth Oppenheimer, M.A. (Oxford) Offenlich bestelite Übersetzerin für die englische Sprache / Publicly appointed translator for German & English Am Graben le, 86925 Fuchstal,...
PIERIS PHARMACEUTICALS, INC.
Biotechnology
2014
Rental account no. 130222 1st upper floor units 1.01 to1.08
PIERIS PHARMACEUTICALS, INC.
Biotechnology
2014
Amendment Agreement between
PIERIS PHARMACEUTICALS, INC.
Biotechnology
2014
CONFIDENTIAL TREATMENT REQUESTED RESEARCH AND LICENSING AGREEMENT between
PIERIS PHARMACEUTICALS, INC.
Biotechnology
2014
CONFIDENTIAL TREATMENT REQUESTED
PIERIS PHARMACEUTICALS, INC.
Biotechnology
2014
CONFIDENTIAL TREATMENT REQUESTED
PIERIS PHARMACEUTICALS, INC.
Biotechnology
NY
2014
CONFIDENTIAL TREATMENT REQUESTED
PIERIS PHARMACEUTICALS, INC.
Biotechnology
2014
CONFIDENTIAL TREATMENT REQUESTED
PIERIS PHARMACEUTICALS, INC.
Biotechnology
2014